Fig. 2
Fragment-based design concept for the new carborane-based anti-cancer agents: a combination of insights from diclofenac (fragment A), oxindoles (fragment B) and carborane-substituted NSAID (fragment C).
Fig. 2 | Scientific Reports
Fragment-based design concept for the new carborane-based anti-cancer agents: a combination of insights from diclofenac (fragment A), oxindoles (fragment B) and carborane-substituted NSAID (fragment C).
